1. Home
  2. CCNE vs PRTC Comparison

CCNE vs PRTC Comparison

Compare CCNE & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCNE
  • PRTC
  • Stock Information
  • Founded
  • CCNE 1865
  • PRTC 2015
  • Country
  • CCNE United States
  • PRTC United States
  • Employees
  • CCNE N/A
  • PRTC N/A
  • Industry
  • CCNE Major Banks
  • PRTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCNE Finance
  • PRTC Health Care
  • Exchange
  • CCNE Nasdaq
  • PRTC Nasdaq
  • Market Cap
  • CCNE 455.3M
  • PRTC 413.5M
  • IPO Year
  • CCNE N/A
  • PRTC N/A
  • Fundamental
  • Price
  • CCNE $23.79
  • PRTC $17.80
  • Analyst Decision
  • CCNE Hold
  • PRTC Buy
  • Analyst Count
  • CCNE 1
  • PRTC 1
  • Target Price
  • CCNE $26.00
  • PRTC $45.00
  • AVG Volume (30 Days)
  • CCNE 75.6K
  • PRTC 5.3K
  • Earning Date
  • CCNE 07-21-2025
  • PRTC 08-27-2025
  • Dividend Yield
  • CCNE 2.97%
  • PRTC N/A
  • EPS Growth
  • CCNE N/A
  • PRTC N/A
  • EPS
  • CCNE 2.34
  • PRTC 0.21
  • Revenue
  • CCNE $219,886,000.00
  • PRTC $4,828,000.00
  • Revenue This Year
  • CCNE $17.91
  • PRTC $35.98
  • Revenue Next Year
  • CCNE $27.71
  • PRTC $115.38
  • P/E Ratio
  • CCNE $10.35
  • PRTC $7.93
  • Revenue Growth
  • CCNE 1.97
  • PRTC 44.98
  • 52 Week Low
  • CCNE $19.32
  • PRTC $13.30
  • 52 Week High
  • CCNE $29.29
  • PRTC $25.00
  • Technical
  • Relative Strength Index (RSI)
  • CCNE 65.00
  • PRTC 48.68
  • Support Level
  • CCNE $23.94
  • PRTC $17.48
  • Resistance Level
  • CCNE $24.44
  • PRTC $18.30
  • Average True Range (ATR)
  • CCNE 0.46
  • PRTC 0.45
  • MACD
  • CCNE 0.16
  • PRTC 0.02
  • Stochastic Oscillator
  • CCNE 82.93
  • PRTC 68.48

About CCNE CNB Financial Corporation

CNB Financial Corp is providing integrated financial solutions, which create value for both consumers and businesses. These solutions encompass deposit accounts, private banking, real estate, commercial, industrial, residential and consumer loans and lines of credit, credit cards, treasury services, online banking, mobile banking, merchant credit card processing, remote deposit and accounts receivable handling. It derives revenue through the operations as a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. The company branch are located in Pennsylvania, Ohio, New York and Virginia.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: